Meet the MEDiSTRAVA team.

Scroll

    Alex Morton

    Senior Vice President,
    Patient Engagement
    Read bio

    Amanda Henkel, PhD

    Practice Area Lead, Rare Disease
    Read bio

    Anthony Haywood

    Vice President, Clinical Trials Optimization
    Read bio

    Aya Takemoto Tokaji

    SVP Medical Affairs, MEDiSTRAVA Japan
    Read bio

    Betsey King

    Senior Vice President,
    Client Services
    Read bio

    Brandon Boland, PhD

    Global Portfolio Lead
    Read bio

    Caroline Lustig

    Vice President, Account Management
    Read bio

    Christopher Jones

    Senior Vice President,
    Scientific Partners
    Read bio

    David Segarnick, PhD

    Chief Medical Officer and Executive Vice President
    Read bio

    David Woods

    Vice President, Medical Analytics and Innovation Portfolio Lead,
    Read bio

    Frazer Hall

    Partner, Corporate and Investor Communications
    Read bio

    Jo Fearnhead-Wymbs

    Senior Vice President,
    Patient Engagement
    Read bio

    Keli Burd

    Vice President, Operations & Project Management
    Read bio

    Lee Dash

    Senior Vice President, Digital Innovation
    Read bio

    Mark Swallow, PhD

    Managing Partner, Corporate and Investor Communications
    Read bio

    Paul Hatton, PhD

    President, Medical Analytics and Innovation
    Read bio

    Phil Wakefield, DPhil

    Global Chief Advisory Services Officer
    Read bio

    Rachel Hatfield, PhD

    Managing Partner
    Read bio

    Sally Alexandroff

    Partner
    Read bio

    Sandi Greenwood

    Senior Consultant, Corporate and Investor Communications
    Read bio

    Sarah Meuler

    Vice President, Insight Liaison
    Read bio

    Sarah Waterson, PhD

    Evidence Strategy & Value Lead
    Read bio

    Sylvie Berrebi

    Senior Consultant, Corporate and Investor Communications
    Read bio

    Tom Carey

    Principal Consultant
    Read bio

What we do.

In rapidly evolving healthcare environments, we help you create the foundations for product approval, access and adoption, and corporate success.      

Our unique integrated offering combines specialized teams in medical strategy and excellence, evidence generation, clinical trials optimization, market access, patient engagement, medical analytics, and corporate and investor communications to provide scalable and targeted solutions and help you maximize your long-term success.

  • Medical strategy and excellence

    We design and deliver customized approaches to accelerate the achievement of your goals and drive transformation within Medical Affairs. Our strategic mindset, analytical skills, therapeutic area knowledge, and understanding of best practices ensure that we create solutions that are meaningful, achievable, and measurable.

    Learn more
  • Patient engagement

    Our dedicated team of patient engagement specialists support you in delivering patient-centric strategy, insights, and education across the drug development lifecycle. Our insights-driven approach ensures the patient voice is incorporated into decision-making and solutions creation, meeting your objectives, and improving outcomes and experience.

    Learn more
  • Clinical trials optimization

    With expertise in complex scenarios, our clinical trials optimization team provides end-to-end support from design through recruitment to real-world implementation. Our team offers specialist consultancy in all aspects of clinical trials, with a focus on enhancing recruitment, quality and risk management, DE&I, and portfolio development and strategy.

    Learn more
  • Medical analytics and innovation

    We help address your most critical challenges through the synergistic combination of medical strategy services, advanced analytics, and digital innovation. We cut through data, opinions, and noise to cultivate actionable insights, bringing together our core areas of expertise to uncover true value at every step.

    Learn more
  • Value and evidence

    We offer consulting and technical execution services through our specialist team. We support Medical and Access professionals along the entire commercialization pathway for all forms of novel medical intervention valuable to patients and healthcare systems - including drugs, vaccines, devices, diagnostics, and technologies.

    Learn more
  • Corporate and investor communications

    Our team works with life sciences companies at all stages of development, as well as specialist VCs, to provide thoughtful planning and execution of communication strategies that shape and amplify corporate, scientific, and medical narratives, with a focus on media, investor, and corporate stakeholders globally.

    Learn more

Contact us.

Learn more about MEDiSTRAVA’s strategic solutions and how we can help your business tackle the unique and evolving needs of leadership and Medical teams.